Immunosuppressive properties of novel FoxA1 expressing Treg cells can be exploited for multiple sclerosis treatment
Independent study uses human venous whole blood from HemaCare to investigate the leukocyte differential count
May 14, 2014 1:00:22 PM / by Maria posted in apoptosis, autoimmune diseases, cell therapy, gene therapy, inflammation, Innovation, leukocyte differential, Multiple Sclerosis, research, Treg Cells, white blood cells
Immunosuppressive properties of novel FoxA1 expressing Treg cells can be exploited for multiple sclerosis treatment
Jan 28, 2014 7:58:23 PM / by Maria posted in Independent validation, Innovation, leukocyte differential, point of care test, research, white blood cells, whole blood
Independent study uses human venous whole blood from HemaCare to investigate the leukocyte differential count